Endothelial dysfunction and restenosis following percutaneous coronary intervention

被引:24
作者
Thanyasiri, Panuratn
Kathir, Krishna
Celermajer, David S.
Adams, Mark R. [1 ]
机构
[1] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW 2050, Australia
关键词
Coronary intervention; Restenosis; Nitric oxide; Endothelium;
D O I
10.1016/j.ijcard.2006.08.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Restenosis remains an important limitation of PCI. Although local factors such as small vessel diameter and systemic factors such as diabetes explain some of its incidence, it nevertheless also occurs in low-risk patients. We hypothesize that endothelial dysfunction may be an independent risk factor in some of these cases. Methods: 20 patients who had previously undergone PCI were studied at cardiac catheterization (10 with restenotic lesions were matched to 10 without restenosis). Infusion of multiple concentrations of acetylcholine (ACh) and nitroglycerine (GTN) were made via a 3F infusion catheter into the target artery. Following infusion, changes in diameter of segments proximal and distal to the PCI site were measured. Results: There was a significant impairment in endothelium-dependent dilatation at the maximal dose of acetylcholine in those with restenosis compared to those without restenosis, both proximal and distal to the stented area (proximal; 11.5 +/- 7.0% versus -20.9 +/- 9.0% p<0.001, distal; 12.0 +/- 3.1% versus -17.8 +/- 8.1% p<0.001), but there was no difference in the response to GTN. There was a significant correlation between the endothelium-dependent dilatation response and the percent restenosis (r=-0.65, p=0.003). Conclusions: Coronary endothelium-dependent dilatation is reduced in subjects with restenosis in arterial segments separate from the stented lesion. This supports a hypothesis that endothelial dysfunction contributes to the development of restenosis, following percutaneous coronary intervention. (C) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:362 / 367
页数:6
相关论文
共 50 条
  • [31] Predicting the Restenosis Benefit of Drug-Eluting Versus Bare Metal Stents in Percutaneous Coronary Intervention
    Yeh, Robert W.
    Normand, Sharon-Lise T.
    Wolf, Robert E.
    Jones, Philip G.
    Ho, Kalon K. L.
    Cohen, David J.
    Cutlip, Donald E.
    Mauri, Laura
    Kugelmass, Aaron D.
    Amin, Amit P.
    Spertus, John A.
    [J]. CIRCULATION, 2011, 124 (14) : 1557 - +
  • [32] Understanding the Role of Endothelial Progenitor Cells in Percutaneous Coronary Intervention
    Padfield, Gareth J.
    Newby, David E.
    Mills, Nicholas L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (15) : 1553 - 1565
  • [33] Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents
    Motoki Kubo
    Toru Miyoshi
    Hiroki Oe
    Yuko Ohno
    Kazufumi Nakamura
    Hiroshi Ito
    [J]. BMC Cardiovascular Disorders, 15
  • [34] Effect of coronary endothelial function on outcomes in patients undergoing percutaneous coronary intervention
    Hamasaki, Shuichi
    Tei, Chuwa
    [J]. JOURNAL OF CARDIOLOGY, 2011, 57 (03) : 231 - 238
  • [35] Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents
    Kubo, Motoki
    Miyoshi, Toru
    Oe, Hiroki
    Ohno, Yuko
    Nakamura, Kazufumi
    Ito, Hiroshi
    [J]. BMC CARDIOVASCULAR DISORDERS, 2015, 15
  • [36] Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: Learning from pathophysiology to optimize treatment
    Mangiacapra, Fabio
    Del Buono, Marco Giuseppe
    Abbate, Antonio
    Gori, Tommaso
    Barbato, Emanuele
    Montone, Rocco Antonio
    Crea, Filippo
    Niccoli, Giampaolo
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2020, 63 (03) : 233 - 242
  • [37] FIBRINOGEN VALUES IN PATIENTS WITH AND WITHOUT RESTENOSIS FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    SCHUMACHER, M
    EBER, B
    TIRAN, A
    TOPLAK, H
    LUHA, O
    GASSER, R
    KLEIN, W
    [J]. CARDIOLOGY, 1992, 80 (5-6) : 345 - 348
  • [38] Detection of Restenosis After Percutaneous Coronary Intervention in Three Major Coronary Arteries by Transthoracic Doppler Echocardiography
    Hyodo, Eiichi
    Hirata, Kumiko
    Hirose, Makoto
    Sakanoue, Yuji
    Nishida, Yukio
    Arai, Kotaro
    Kawarabayashi, Takahiko
    Shimada, Kenei
    Hozumi, Takeshi
    Muro, Takashi
    Homma, Shunichi
    Yoshikawa, Junichi
    Yoshiyama, Minoru
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2010, 23 (05) : 553 - 559
  • [39] Recruitable collateral blood flow index predicts coronary instent restenosis after percutaneous coronary intervention
    Jensen, Lisette Okkels
    Thayssen, Per
    Lassen, Jens Flensted
    Hansen, Henrik Steen
    Kelbaek, Henning
    Junker, Anders
    Pedersen, Knud Erik
    Hansen, Knud Norregaard
    Krusell, Lars Romer
    Botker, Hans Erik
    Thuesen, Leif
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 (15) : 1820 - 1826
  • [40] Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention
    Monraats, P. S.
    Kurreeman, F. A. S.
    Pons, D.
    Sewgobind, V. D. K. D.
    de Vries, F. R.
    Zwinderman, A. H.
    de Maat, M. P. M.
    Doevendans, P. A.
    de Winter, R. J.
    Tio, R. A.
    Waltenberger, J.
    Huizinga, T. W. J.
    Eefting, D.
    Quax, P. H. A.
    Frants, R. R.
    van der Laarse, A.
    van der Wall, E. E.
    Jukema, J. W.
    [J]. GENES AND IMMUNITY, 2007, 8 (01) : 44 - 50